NS
Noone Sreenivasa Rao
About Noone Sreenivasa Rao
Data last updated:
Noone Sreenivasa Rao is a Director at Ncyte Pharma Private Limited (since 2018). The companies operate in Business Services. Ncyte Pharma Private Limited reported revenue of ₹60.9 Lakh (FY 2024). Earlier, Noone Sreenivasa Rao was a Director at Novosun Healthcare Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ncyte Pharma Private Limited U74999TG2018PTC128505 | Director | 26 Nov 2018 | 2018 | ₹60.9 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Novosun Healthcare Private Limited U51397TG2019PTC132743 | Director | 15 May 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Noone Sreenivasa Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Radhika Noone | 08286975 | Ncyte Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Noone Sreenivasa Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noone Sreenivasa Rao
Noone Sreenivasa Rao currently holds 1 directorship: Ncyte Pharma Private Limited (Director, since 26 Nov 2018, revenue ₹60.9 Lakh (FY 2024)).
Noone Sreenivasa Rao was first appointed on 26 Nov 2018 as Director at Ncyte Pharma Private Limited. The most recent appointment on record is 15 May 2019 at Novosun Healthcare Private Limited.
Noone Sreenivasa Rao held 1 earlier board appointment: Novosun Healthcare Private Limited (Director, from 15 May 2019).
The current boards of Noone Sreenivasa Rao's companies include Radhika Noone (Ncyte Pharma Private Limited).